Cristina Falci

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study

L Campana, Sara Valpione, Cristina Falci et al. · Breast Cancer Research and Treatment · 2012 · 103 citations

Medicine, Oncology, Surgery +14

Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)

Andrea Luciani, Laura Biganzoli, Giuseppe Colloca et al. · Journal of Geriatric Oncology · 2015 · 75 citations

Medicine, Geriatric Medicine, Oncology +16

Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease

Maria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo et al. · Frontiers in Oncology · 2019 · 71 citations · Full text

Medicine, Cancer Biology, Oncology +16

Management of Frail and Not-Frail elderly cancer patients in a hospital-based geriatric oncology program

Umberto Basso, S. Tonti, Catia Bassi et al. · Critical Reviews in Oncology/Hematology · 2008 · 69 citations

Medicine, Geriatric Medicine, Oncology +14